ScholarIQanswers from OpenAlex

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial

PaperCitations, authors & open-access status

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial have?

ScholarIQcitation count

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial has 167 citations in the OpenAlex counts ScholarIQ stores.

When was Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial published?

ScholarIQyear

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial has 2020 year in the ScholarIQ index.

What is the open-access status of Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial?

ScholarIQoa status

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial has closed oa status in the ScholarIQ index.

What is the DOI of Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial?

ScholarIQdoi

The DOI for Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial is on the source record.

What is the PMID of Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial?

ScholarIQpmid

The PMID for Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial is on the source record.

What is the OpenAlex record for Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial?

ScholarIQopenalex

The OpenAlex for Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial